全球脊髓刺激市场 - 市场规模、份额、增长分析：按技术类型、按应用 - 行业预测（2023-2030）

Global Spinal Cord Stimulation Market Size, Share, Growth Analysis, By Technology Type(Rechargeable, Non-Rechargeable), By Application(Failed back surgery syndrome, Complex Regional Pain Syndrome) - Industry Forecast 2023-2030

出版日期: 2023年07月19日 | 出版商:

SkyQuest | 英文 165 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计2021年全球脊髓刺激市场规模为30.2亿美元，2022年为32.5亿美元。预计该市场在预测期内（2023-2030年）将以7.58%的复合年增长率扩张，到2030年达到58.3亿美元。

脊髓刺激器 (SCS)，也称为背柱刺激器，是一种植入体内用于治疗慢性疼痛的神经刺激器。它的工作原理是发出电信号来阻止疼痛信号，缓解与脊髓、背部、手臂和腿部相关的症状。这种治疗对于对药物或其他传统治疗没有反应的慢性疼痛患者特别有益。

由于技术进步、SCS 手术指南的製定以及微创疗法的日益采用，全球脊髓刺激 (SCS) 市场正在经历显着增长。这些因素正在推动全球对 SCS 的关注和需求。此外，由于久坐的生活方式，人群中慢性疼痛的高患病率进一步促进了市场的扩张。在神经刺激技术日益普及的推动下，当前的市场繁荣预计将在未来创造更多机会。

持续的技术进步和政府指导方针正在推动脊髓刺激器市场的增长。製造商致力于使设备更小、更高效，从而推动更先进的脉衝生产的发展。此外，政府机构正在製定使用脊髓刺激疗法治疗慢性疼痛和其他疾病的建议和指南。美国国家健康与护理卓越研究所发布的指南正在鼓励脊髓刺激器的市场和采用。

政府为减少阿片类药物依赖所做的努力增加了对替代疗法的需求，包括脊髓刺激器。美国、欧洲和其他国家政府积极支持非阿片类疼痛管理设备的开发和批准。Medtronic、Abbott和Boston Scientific等医疗器械公司正在投资研发，以抓住这一不断增长的市场机会。

该报告研究了全球脊髓刺激市场，并提供了市场概述，包括按技术类型、应用、地区和参与市场的公司概况划分的趋势。

主要公司简介
- Medtronic
- Boston Scientific Corporation
- Abbott Laboratories
- Stimwave LLC
- Nuvectra Corporation
- Saluda Medical Pty Ltd
- Synapse Biomedical Inc.
- NeuroSigma, Inc.
- Axonics Modulation Technologies, Inc.
- SPR Therapeutics, Inc
- Cyberonics, Inc.
- Inspire Medical Systems, Inc.
- ReShape Lifesciences Inc
- LivaNova PLC
- Integer Holdings Corporation
- Nevro Corp.
- Stryker Corporation
- Zynex, Inc.
- StimGuard LLC.

简介目录

Product Code: SQSG35A2012

Spinal Cord Stimulation Market size was valued at USD 3.02 billion in 2021 and is poised to grow from USD 3.25 billion in 2022 to USD 5.83 billion by 2030, growing at a CAGR of 7.58% in the forecast period (2023-2030).

The spinal cord stimulator (SCS), also known as the dorsal column stimulator, is a neurostimulation device implanted in the body to treat chronic pain. It works by emitting electric signals that block pain signals, providing relief for conditions related to the spinal cord, back, arms, and legs. This therapy is particularly beneficial for patients with chronic pain who have not responded to medication or other traditional treatments.

The global SCS market is experiencing significant growth due to advancements in technology, the establishment of guidelines for SCS procedures, and the increasing adoption of minimally invasive therapies. These factors are driving the attention and demand for SCS globally. Additionally, the high prevalence of chronic pain in the population, attributed to sedentary lifestyles, further contributes to the market's expansion. The current boom in the market is expected to create more opportunities in the future, fueled by the growing adoption of neurostimulation techniques.

Segments covered in this report

Spinal Cord Stimulation Market segmentation is based on technology type, application and region. Based on technology type the market is segmented into rechargeable and non- rechargeable types. Based on application, the market is segregated into failed back surgery syndrome, complex regional pain syndrome, arachnoiditis, sciatica, degenerative disc disease and others. Based on region the Spinal Cord Stimulation Market is segmented into North America, Europe, Asia-Pacific and Rest of the world

Driver

Continuous technological advancements and government guidelines are driving the growth of the spinal cord stimulator market. Manufacturers are focusing on making devices smaller and more efficient, leading to the development of more advanced impulse production. Additionally, government associations are establishing recommendations and guidelines for the use of spinal cord stimulation therapy in treating chronic pain and other conditions. These guidelines, such as those released by the National Institute for Health and Care Excellence, are encouraging market activity and adoption of spinal cord stimulators.

Restraint

The high costs associated with spinal cord stimulator implantation and the uneven distribution of medical services are posing challenges to market growth. The surgery costs can vary significantly depending on factors such as insurance coverage and out-of-pocket expenses. Additionally, the ongoing maintenance expenses and replacement costs further contribute to the financial burden for patients. Moreover, the lack of availability of healthcare equipment in remote locations limits treatment options for the local population, leading to a dependency on larger towns for necessary medical care. These factors are likely to impede the growth of the market.

Market Trends

Government initiatives aimed at reducing opioid dependence have led to an increased demand for alternative therapies, including spinal cord stimulation devices. Governments in the U.S., Europe, and other countries are actively supporting the development and approval of non-opioid pain management devices. Medical device companies like Medtronic, Abbott, and Boston Scientific are investing in research and development to capitalize on this growing market opportunity.

Technological advancements in the field of spinal cord stimulation are also driving market growth. Miniature devices are being developed, and customization techniques such as remote-control options, rechargeable batteries, and wireless connectivity are being incorporated into the devices. These advancements allow for more personalized and convenient treatment options in the healthcare sector.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Spinal Cord Stimulation Market by Technology Type

Market Overview
Rechargeable
Non-Rechargeable

Global Spinal Cord Stimulation Market by Application

Market Overview
Failed back surgery syndrome
Complex Regional Pain Syndrome
Arachnoiditis
Sciatica
Degenerative Disc Disease
Others

Global Spinal Cord Stimulation Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stimwave LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nuvectra Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Saluda Medical Pty Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synapse Biomedical Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeuroSigma, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Axonics Modulation Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SPR Therapeutics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cyberonics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inspire Medical Systems, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ReShape Lifesciences Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integer Holdings Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nevro Corp.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zynex, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
StimGuard LLC.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments